Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
Innovative Nitric Oxide Delivery Device Company Announces Addition of FDA Advisor SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) —
Read moreInnovative Nitric Oxide Delivery Device Company Announces Addition of FDA Advisor SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) —
Read moreWEST PALM BEACH, Fla, April 09, 2019 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”),
Read moreREHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics
Read moreWEST PALM BEACH, Fla., Feb. 20, 2019 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the
Read moreMIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further
Read moreCARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based
Read moreSAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company,
Read moreHANOVER, MD, Jan. 29, 2019 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products
Read moreVANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (C:BOSS) (OTC:BOSQF) (Frankfort: YG3) announces completion of the
Read moreTEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its
Read moreEight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE)
Read moreMIAMI, Jan. 17, 2019 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Progressive Care
Read more